Michael Stein

Oxstem Ltd. develops cell programming therapies. The company is headquartered in Oxford, the United Kingdom.

Map of Medicine Ltd. publishes a web-based database of medical content. The firm offers comprehensive, evidence-based local guidance and clinical decision support at the point of care. The company was founded in 2000 and is headquartered in London, the United Kingdom.

ResApp Health Ltd. engages in the research and commercial development of ResApp technology for the purpose of providing health care solutions for respiratory disease. The technology is based on a machine learning algorithm that uses sound alone without the need for additional hardware to diagnose and measure the severity of a respiratory condition. ResApp’s core technology uses sound to diagnose respiratory diseases including pneumonia, bronchiolitis, bronchitis, chronic obstructive pulmonary disease and asthma. The company was founded on September 13, 2000 by John Majewski and is headquartered in Brisbane, Australia.

Doctor Care Anywhere Ltd. provides healthcare services via video and phone consultation. It offers prescriptions, referrals and fit notes, health tracking, and patient record services. The company was founded by Farzad Entikabi, Michael Stein and Bayju Thakar in 2013 and is headquartered in London, the United Kingdom.

Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020.